Gene symbol | IL32 | Synonyms | IL-32alpha, IL-32beta, IL-32delta, IL-32gamma, NK4, TAIF, TAIFa, TAIFb, TAIFc, TAIFd | Type of gene | protein-coding |
Chromosome | 16 | Map location | 16p13.3 | dbXrefs | |
Description | interleukin 32 |
GTO ID | GTC1126 |
Trial ID | JPRN-UMIN000015771 |
Disease | Malignant Pleural Mesothelioma |
Altered gene | NK4 |
Therapeutic/Target gene | Therapeutic gene |
Therapy | Gene transfer |
Treatment | AdV-NK4 |
Phase | Phase1 |
Recruitment status | Not Recruiting |
Title | Phase 1 clinical trial of an intrathoracic administration of adenoviruses harboring the NK4 gene (AdCMV-NK4) for subjects with unresectable malignant pleural mesothelioma |
Year | 2015 |
Country | Japan |
Company sponsor | Duke Clinical Research Institute |
Vector information | |||||||||||
|
Cohort1: dose level 1 | |||||||
|
|||||||
Cohort2: dose level 2 | |||||||
|
|||||||
Cohort3: dose level 3 | |||||||
|